During the past decade, Dubbo Base Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dubbo Base Hospital" #1 sponsor was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials, followed by "Pfizer" with 1 trials sponsored, "Smith & Nephew, Inc." with 1 trials sponsored, "South West Sydney Local Health District" with 1 trials sponsored and "UMC Utrecht" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dubbo Base Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Research Centre" with 1 trials as a collaborator, "Berry Consultants" with 1 trials as a collaborator, "Catholic Health Care Services" with 1 trials as a collaborator, "Global Coalition for Adaptive Research" with 1 trials as a collaborator and "Greater Western Area Health Service" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Dubbo Base Hospital" are "Arthritis, Degenerative" (1 trials), "Castration Resistant Prostatic Cancer" (1 trials), "Choledocholithiasis" (1 trials), "Cholelithiasis" (1 trials) and "Community-acquired Pneumonia, Influenza, COVID-19" (1 trials). Many other conditions were trialed in "Dubbo Base Hospital" in a lesser frequency.

Most popular intervention types in "Dubbo Base Hospital" are "Biological" (2 trials), "Drug" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "ARB + DMX-200" (1 trials), "Amoxicillin-clavulanate" (1 trials), "Anakinra" (1 trials), "Angiotensin Receptor Blockers" (1 trials) and "Angiotensin converting enzyme inhibitor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dubbo Base Hospital" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dubbo Base Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Dubbo Base Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Dubbo Base Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".